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ABSTRACT
The transcription factor Gata1 is essential for the
development of erythroid cells. Consequently,
Gata1 null mutants die in utero due to severe anae-
mia. Outside the haematopoietic system, Gata1 is
only expressed in the Sertoli cells of the testis. To
elucidate the function of Gata1 in the testis, we
made a Sertoli cell-speci®c knockout of the Gata1
gene in the mouse. We deleted a normally function-
ing `¯oxed' Gata1 gene in pre-Sertoli cells in vivo
through the expression of Cre from a transgene
driven by the Desert Hedgehog promoter. Sur-
prisingly, Gata1 null testes developed to be mor-
phologically normal, spermatogenesis was not
obviously affected and expression levels of putative
Gata1 target genes, and other Gata factors, were not
altered. We conclude that expression of Gata1 in
Sertoli cells is not essential for testis development
or spermatogenesis in the mouse.
INTRODUCTION
The Gata transcription factor family consists of six members
(Gata1±6). The family is divided into two groups, the
haematopoietic (Gata1, 2 and 3) (1) and the heart and gut
group (Gata4, 5 and 6) (2). The members share their highest
homology in the Zn-®nger DNA-binding domain and they all
bind to the consensus site (T/A)GATA(A/G). Outside the
DNA-binding domain, they are quite different. Most members
are important for the proliferation and differentiation of
speci®c cell types. Gata factors are thought to be important
transcriptional regulators of Sertoli cell-speci®c gene expres-
sion (3,4). Many Sertoli cell-speci®c genes have Gata-binding
sites in their promoters (4), and these Gata sites are essential
for optimal or appropriate expression of reporter genes (4).
Sertoli cells are known to express Gata1, 4 and 6 (5,6).
Gata1 is a tissue-speci®c transcription factor expressed in
erythrocytes, megakaryocytes, eosinophils and mast cells (7±
11). The major haematopoietic role of Gata1 is its requirement
for the progression of erythroid precursor cells beyond the
proerythroblast stage (12). Outside the haematopoietic system,
Gata1 is exclusively expressed in the Sertoli cells of the testis
(6,13). In the mouse and the rat gene, a haematopoietic and a
testis-speci®c promoter have been described (13). Based on
expression analysis, it has been suggested that Gata1 is a
developmental stage- and spermatogenic cycle-speci®c regu-
lator of gene expression in Sertoli cells (5). Although
conclusive evidence for Gata1 target genes in Sertoli cells is
still lacking, it has been proposed that the gene for anti-
Mullerian hormone (Amh), also known as Mullerian-
inhibiting substance (Mis), is a Gata target gene (14). The
model implies that Gata4 acts as a positive regulator of Amh
expression in late fetal/early postnatal pre-Sertoli cells, while
Gata1 acts as a repressor of Amh expression at later
developmental stages (14,15). The spatio-temporal expression
patterns of the factors conform to this model (15,16), and two
perfect Gata-binding sites are essential for the function of the
Amh promoter in tissue culture cells (15). Furthermore, it has
been reported that two human males harbouring a mutation in
the GATA1 gene displayed cryptorchidism (17). Cryptor-
chidism is also observed in mice overexpressing Amh under
the metallothionein-1 promoter (18). However, cryptorchid-
ism has not been reported for X-linked-thrombocytopenic
males with different GATA1 mutations (19,20). Other Sertoli
cell-speci®c candidate target genes of Gata1 are the follicle-
stimulating hormone receptor (Fshr), inhibin a-subunit and
inhibin/activin b-B-subunit. For Fshr, this notion is based on
the presence of a conserved Gata site in the core promoter of
the gene. This site can bind Gata1 in vitro, and is occupied in
Sertoli cells as revealed by in vivo footprinting (21). The
potential role of Gata1 in the expression of the inhibin
a-subunit and inhibin/activin b-B-subunit genes is deduced
from transient transfection assays with a bacterial reporter gene
driven by the corresponding promoters in the rat testicular
Leydig tumour cell line MA-10 and the mouse Sertoli cell line
MSC-1 (22,23). In these studies, the Gata sites were essential
for expression. In addition to this, the expression of the inhibin
a-subunit and the inhibin/activin b-B-subunit occurs in a
spatio-temporal pattern similar to that of Gata1 (24±26).
However, these functional experiments were performed in
transiently transfected cell lines, and the results may therefore
not re¯ect the in vivo roles of Gata1 appropriately.
The Gata1 null mutation is embryonic lethal due to a
block in erythropoiesis at the proerythroblast stage (12). To
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overcome this early embryonic lethality, we created a
conditional knockout allele of the Gata1 gene employing the
Cre-loxP system (27). To delete the ¯oxed Gata1 gene in pre-
Sertoli cells, we established transgenic mouse lines expressing
Cre recombinase under the control of the Desert Hedgehog
promoter. This promoter is active in the nervous system and
Sertoli cell precursors early in testis development (28). Since it
is not active in haematopoietic cells, the ¯oxed Gata1 gene
remains active in erythroid cells of Gata1¯oxed:y::Dhh-Cre
compound animals, thus allowing us to study the role of Gata1
in testis during development and adulthood.
MATERIALS AND METHODS
Construction of the ¯oxed Gata1 locus
The 3¢ homologous region is an EcoRI fragment 3¢ from the
last exon isolated from the Gata1 locus-containing cosmid
(pTCF 3¢mGata1). A BamHI±SalI fragment containing all the
coding exons was cloned into a low copy number plasmid
(pSC3Z mGata1 genomic). In this construct, the 5¢ lox site
was inserted in an EcoRI site in the intron between the ®rst
erythroid non-coding exon (IE) and the second exon (II).
In plasmid pGT1.8 IRES bgeo (29), the IRES and the
lacZ gene were replaced (SacI±XhoI/blunt) with a green
¯uorescent protein (GFP) gene from the plasmid phGFP-S65T
(SacI±BamHI/blunt). The cassette with the splice acceptor,
GFP and the neomycin/G418 selectable marker was excised
with SalI.
The 3¢ loxP site (in XhoI), the GFP cassette (in SalI) and the
3¢ homologous region (in EcoRI) were put together in
pBluescript and taken out with SpeI and PvuI. This fragment
was inserted in the SalI site (3¢ of the sixth and last exon) of the
pSC3Z mGata1 gene with the 5¢ loxP site (see Fig. 1). The
construct was linearised with SpeI and used to electroporate
E14 embryonic stem (ES) cells.
ES cells
E14 ES cells were electroporated with the targeting construct
and grown in medium containing G418 to select for integra-
tion of the neomycin gene. Approximately 300 clones were
picked and screened by Southern blotting for homologous
recombination in the Gata1 locus. The genomic DNA was
digested with XbaI and the blot was hybridised with a probe
(EcoRI±XbaI fragment) that is adjacent to the 3¢ homology
region (Fig. 1). Positive ES cell clones were transfected with a
vector expressing Cre under the PGK promoter and a
hygromycin resistance marker. Clones were screened for
recombination by Southern blot analysis, using a probe
(BamHI±NcoI fragment) just before the 5¢ loxP site (Fig. 1).
DNA constructs and mice
We inserted the SV40 large T antigen nuclear localisation
signal (NLS) at the N-terminus of Cre (30). The Dhh-Cre
construct was prepared by introducing NLS-Cre in the ®rst
exon of the mouse Dhh gene, at the NcoI site coinciding with
the initiation codon of the Dhh protein (28). A 20 kb NotI
fragment was puri®ed and used to generate transgenic mice
according to standard procedures (Fig. 2A). The spatio-
temporal expression pattern of Cre was assessed using the
ROSA26 reporter strain R26R in which expression of the lacZ
reporter gene is dependent on Cre-mediated recombination
(31). Testes were isolated from Dhh-Cre/R26R compound
males at day 18 of embryonic development, and day 15 after
birth, and stained for b-galactosidase activity as described
previously (32).
Chimeric mice were generated by injecting ES cells from
the clones described above into C57BL/6 blastocysts.
Chimeras were bred with wild-type C57BL/6 mice and
screened for germline transmission. Gata1¯oxed:¯oxed female
mice were mated to FVB males carrying the Dhh-Cre
transgene to generate Gata1¯oxed:y::Dhh-Cre compound trans-
genic males. To obtain sperm counts, seminal vesicles were
isolated, ¯ushed with phosphate-buffered saline (PBS), and a
fraction of the cells was counted manually under the
microscope.
RT±PCR and RQ±PCR
RNA was isolated with the tri reagent procedure according to
the manufacturer's instructions (Sigma, St Louis, MO). A 5 mg
aliquot of RNA was used for the reverse transcription reaction
with oligo(dT) (18mer) and random hexamers. Real-time
quantitative (RQ)±PCR was performed in triplicate reactions
on a Bio Rad iCycler machine, using the Eurogentec (Seraing,
Belgium) SYBR green kit. The oligonucleotides used for
RT±PCR and RQ±PCR are listed in Table 1.
RESULTS
Introduction of loxP sites in the mouse Gata1 locus
To create a `¯oxed' allele of the mouse Gata1 gene, we
designed a targeting construct in which the coding exons of the
Gata1 gene are ¯anked by loxP sites (Fig. 1A). The 5¢ loxP site
was inserted in an EcoRI site in the ®rst intron, between
erythroid exon 1 and exon 2. The 3¢ loxP was placed behind
exon VI in the 3¢-¯anking region of the gene. The integrity and
orientation of the loxP sites were determined by sequencing. A
splice acceptor sequence, GFP cDNA and neomycin-
selectable marker gene were introduced 3¢ to the downstream
loxP site, with the aim of activating GFP expression after Cre-
mediated excision of the Gata1 coding sequences. E14 ES
cells were electroporated with the targeting construct, and
transformants were selected by growth in medium containing
G418. Homologous recombination events were scored by
Southern blot analysis. This revealed that of approximately
300 clones analysed, ~10% had recombined correctly at the 3¢
end of the construct. Several clones were transfected with a
Cre expression vector and screened for recombination. In one
of these, we could demonstrate appropriate recombination
(Fig. 1B). This clone was karyotyped and used for blastocyst
injections. Chimeric mice were born and mated with C57BL/6
females. Offspring were checked for the conditional knockout
(`¯oxed') Gata1 locus and backcrossed to FVB mice. In
further generations, hemizygous and homozygous ¯oxed
Gata1 mice were born according to Mendelian distribution.
These mice were healthy and fertile with no apparent
phenotype, indicating that expression of Gata1 was not
disturbed by the presence of two loxP sites and the GFP±neo
cassette in the locus.
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Expression of Cre recombinase in Sertoli cells
To drive expression of Cre recombinase in the Sertoli cell
compartment of the testis, we used an ~19 kb fragment of the
Dhh gene. We introduced an NLS of the SV40 large T antigen
at the N-terminus of Cre (30), and cloned this modi®ed version
of Cre in the initiation codon of the Desert Hedgehog protein
(Fig. 2A). Vector sequences were removed by NotI digestion,
and the ~20 kb insert was puri®ed and used to generate
transgenic mice. Two independent transgenic lines were
obtained. To validate the expression pattern of Cre in these
mice, they were crossed with a reporter strain in which
expression of the bacterial gene for b-galactosidase (lacZ) is
dependent upon Cre-mediated recombination [R26R (31)].
Since the reporter construct is knocked into the ROSA26 locus,
activation of lacZ expression can be monitored in every cell
type at every stage of development (31). We isolated testes
from male Dhh-Cre/R26R embryos at day 18 of gestation
(E18), i.e. before Gata1 expression is activated, and at day 15
after birth (P15) when Gata1 expression peaks in Sertoli cells,
just before the onset of spermatogenesis (5,6). As controls, we
used testes from males carrying only the Dhh-Cre transgene or
the R26R allele. We performed staining for lacZ activity on
whole mounts of these testes. In the controls, no lacZ activity
could be detected (data not shown). This is in contrast to the
Dhh-Cre/R26R testes, which displayed strong blue staining,
Figure 1. A conditional allele of the Gata1 gene. (A) The mouse Gata1 locus, with the testis-speci®c ®rst exon (IT) ~8 kb upstream of the erythroid-speci®c
®rst exon (IE). The coding exons (II±VI) are common to both mRNAs. After homologous recombination with the targeting vector, the Gata1 locus has two
loxP sites and the splice acceptor/GFP cassette inserted, and is referred to as the `¯oxed' locus. After recombination of the ¯oxed Gata1 locus, the coding
exons are deleted and the GFP transcript should be expressed. (B) Southern blot of BamHI-digested DNA from ES cells harbouring the ¯oxed Gata1 locus,
before and after Cre transfection. Left panel: the blot was hybridised with a Gata1 cDNA probe. Because the coding sequences are removed upon recombina-
tion, no band is detected with the cDNA probe after recombination. Right panel: same blot, re-hybridised with the 5¢ probe (A). The size of the 10 kb band is
reduced to 3.4 kb after recombination.
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indicating that the lacZ gene had been activated through Cre-
mediated recombination (Fig. 2B). In cross-sections of E18
testes, we observed that staining was restricted to the pre-
Sertoli cells in the testis cords, and endothelial cells of the
walls of the blood vessels (Fig. 2B, a). This is in agreement
with the expected expression pattern of the Dhh gene in the
testis (28). Importantly, we observe blue staining of all the pre-
Sertoli cells in consecutive sections across the testis. This
demonstrates that the Dhh-Cre transgene is expressed
pancellularly in pre-Sertoli cells, before Gata1 expression is
activated. Furthermore, the same staining pattern is found at
P15, just before the onset of spermatogenesis when Gata1 is
expressed abundantly in the Sertoli cells. A whole mount of
P15 testis is shown in Figure 2B, b. We conclude that the Dhh-
Cre transgenics can be used to delete the ¯oxed Gata1 gene in
the Sertoli cell compartment. Since the Dhh-Cre transgene is
already active in pre-Sertoli cells, i.e. at a stage preceding the
normal activation of Gata1 expression in this lineage, it can be
used to assess the role of Gata1 in Sertoli cell function.
Although the Dhh-Cre transgene is also expressed in other cell
types, e.g. endothelial cells (Fig. 2B, b) and Schwann cells
of the peripheral nervous system (M.Jaegle, M.Uyl and
D.Meijer, in preparation), these cell types never express
Gata1 and deletion of the Gata1 gene would therefore be of no
consequence to these cell types. Since we obtained essentially
the same results with both Dhh-Cre transgenic lines, we used
one of the lines (line a2) for the experiments described below.
A Sertoli cell-speci®c knockout of the Gata1 gene
To create a knockout of the Gata1 gene in the Sertoli cell
compartment, ¯oxed Gata1 mice were crossed with the Dhh-
Cre transgenic mice. In male offspring, Cre-mediated
recombination at the Gata1 locus occurred only in mice
harbouring the Dhh-Cre transgene and the ¯oxed Gata1 allele
(Gata1¯oxed:y::Dhh-Cre), as demonstrated by the complete
absence of Gata1 mRNA in RT±PCR analysis of P14 testis
RNA from compound mutant males (Fig. 3). Gata1 mRNA
was also not detectable by RQ±PCR analysis of these samples.
The threshold cycle for Gata1 expression in control testis was
30. With a maximum of 40 cycles performed and assuming an
ampli®cation ef®ciency of 1.8-fold per cycle, the Gata1
mRNA levels in the testes of compound mutant males are
reduced at least 350-fold. We were unable to detect GFP
expression by RT±PCR or by ¯uorescence microscopy. The
Dhh-Cre transgene is also expressed in endothelial cells and
the Schwann cells of the peripheral nervous system. However,
Gata1 is not expressed in these cells and it is therefore not
surprising that the compound mutant males did not show
any obvious vascular abnormalities or neuropathological
Table 1. Oligonucleotides used for RT±PCR and RQ±PCR
Gene Sense and antisense primer Product
size (bp)
Amh 5¢-AGCTGGACACCATGCCTTTC-3¢
5¢-AGGGTCTCTAGGAAGGGGTC-3¢ 88
Cyclophilin A 5¢-TCACCATTTCCGACTGTGGAC-3¢
5¢-ACAGGACATTGCGAGCAGATG-3¢ 120
Cyp 19 5¢-TCGAGTACTTCCCTAAGCCC-3¢
5¢-GCCAAAAGGCTGAAAGTACC-3¢ 83
Fshr 5¢-GCAAACTGGAGGCGGCAAAC-3¢
5¢-TCTGATCCCCAGGCTGAGTC-3¢ 97
Gata1 5¢-TCCTCTGCATCAACAAGCCCA-3¢
5¢-GTTGAGCAGTGGATACACCTG-3¢ 297
Gata2 5¢-AGAACCGGCCGCTCATCAAG-3¢
5¢-GGTGGTGGTTGTCGTCTGAC-3¢ 92
Gata4 5¢-TCTCACTATGGGCACAGCAG-3¢
5¢-ACAGCACTGGATGGATGGAG-3¢ 82
Gata6 5¢-ATCCCAGAACCCATTCATCC-3¢
5¢-AGACCAAATGGCTCCCAGTG-3¢ 82
Hprt 5¢-CACAGGACTAGAACACCTGC-3¢
5¢-GCTGGTGAAAAGGACCTCTC-3¢ 247
Inhibin-a 5¢-CTCCCAGGCTATCCTTTTCC-3¢
5¢-AGTGAAGAGGCCTTCCTCAG-3¢ 97
Inhibin-b-A 5¢-AGCAGACCTCGGAGATCATC-3¢
5¢-CTGCCTTCCTTGGAAATCTC-3¢ 82
Inhibin-b-B 5¢-AAACAATCCTTCGAGTGGCC-3¢
5¢-GGGTGTGTACGGACAGAAAAG-3¢ 98
Star 5-GGAAGTCCCTCCAAGACTAAAC-3¢
5¢-TGGTTGATGATTGTCTTCGG-3¢ 80
Figure 2. Expression of Cre in Sertoli cells driven by Dhh genomic sequen-
ces. (A) Dhh-Cre construct used to make transgenic mice. Dhh exons are in
green; Cre-encoding sequences in red. B = BamHI; N = NotI. (B) (a) LacZ-
stained section of E18 Dhh-Cre/R26R transgenic testis. CE = coelomic
epithelium; TC = testis cords. Arrows point to pre-Sertoli cells; arrowheads
indicate endothelial cells. Original magni®cation 253. (b) LacZ-stained
whole mount of P15 Dhh-Cre/R26R transgenic testis. All testis cords are
stained intensely blue. Original magni®cation 2.53.
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symptoms. Since the mice develop to maturity, it can be
concluded that the Dhh-Cre transgene does not express the Cre
protein in erythroid precursor cells, in agreement with the
analysis of the Dhh-Cre/R26R mice described above. Because
the Dhh-Cre transgene is active in fetal Sertoli cell precursors
(Fig. 2B, a), long before Gata1 is normally expressed, we
conclude that the Gata1¯oxed:y::Dhh-Cre compound males,
unlike control males, have never expressed the Gata1 protein
in their Sertoli cell compartment.
Fertility of Gata1¯oxed:y::Dhh-Cre males
Breeding performance of the compound mutant males was
similar to that of control males. Litters produced by matings
between compound mutant males and wild-type FVB females
had an average size of eight pups, and the distribution between
male and female pups was as expected (32 male pups versus
30 female pups, i.e. 52 versus 48%). Compound mutant males
remained fertile until at least 18 months of age. To further
analyse the testicular function of Gata1¯oxed:y::Dhh-Cre males,
testes, epididymides and seminal vesicles of Gata1¯oxed:y and
Gata1¯oxed:y::Dhh-Cre littermates of different ages were
isolated. We compared the weights and gross morphology of
these organs, but found no signi®cant differences between the
two groups. Sperm was isolated from epididymides and the
sperm cell numbers were counted. Within the same age
groups, no signi®cant differences were observed between the
mice analysed (Table 2). Collectively, we conclude that
fertility and testicular function of Gata1¯oxed:y::Dhh-Cre
compound males are apparently normal.
Expression of potential Sertoli cell-speci®c Gata1 target
genes
To determine whether the expression of putative Sertoli cell-
speci®c Gata1 target genes was affected in Gata1¯oxed:y::Dhh-
Cre males, we isolated RNA from testes of 2-week-old
Gata1¯oxed:y::Dhh-Cre and Gata1¯oxed:y mice. At this age, the
testis is composed for a large part of Sertoli cells, because the
process of spermatogenesis is just starting. Furthermore,
Gata1 expression normally peaks at this stage of testicular
maturation (5). We performed an RQ±PCR analysis to
compare the expression of putative Gata1 target genes Amh,
Fshr, inhibin a-subunit and activin/inhibin b-A- and b-B-
subunit. In addition, we determined the expression of Star
(steroidogenic acute regulatory protein) and Cyp19 (PII
aromatase) since these genes have essential Gata sites in
their regulatory elements (33,34). We used the expression
levels of Hprt and cyclophilin A as internal controls for the
RQ±PCRs. We observed no signi®cant differences in the
expression levels of any of the genes analysed (Table 3). Thus,
we conclude that Gata1 function is not essential for the
appropriate regulation of the expression of these genes in
Sertoli cells.
Expression of other Gata family members
In erythroid Gata1 null cells, the transcription of Gata2
is highly upregulated, implying some interchangeability
between Gata factors (35). Furthermore, negative regulation
of Gata2 transcription by Gata1 has been suggested (35).
Finally, a transgene driving expression of Gata2 or Gata3
cDNA under Gata1 regulatory sequences can rescue the
embryonic lethal phenotype of Gata1 knockdown mice (36).
To test whether there might be such a compensatory activity of
other Gata factors in the testis of Gata1¯oxed:y::Dhh-Cre males,
we performed an RQ±PCR analysis to detect transcript
levels of the different Gata family members that are
expressed in the testis. We observed no signi®cant
differences in the expression levels of Gata2, Gata4 and
Gata6 in testis RNA isolated from 2-week-old
Gata1¯oxed:y::Dhh-Cre and Gata1¯oxed:y mice (Table 3). It is
therefore unlikely that the absence of phenotypic conse-
quences in Sertoli cell function of Gata1¯oxed:y::Dhh-Cre mice
is due to compensatory upregulation of another Gata factor.
However, it remains possible that Gata1 function is masked by
the presence of these factors at levels similar to those observed
in normal Sertoli cells.
Figure 3. The Dhh-Cre transgene abolishes testis-speci®c Gata1 expression
from the ¯oxed Gata1 allele. Testes were isolated from P14 Gata1¯oxed:y
and Gata1¯oxed:y::Dhh-Cre mice. RNA was extracted from total testis, and
expression of Gata1 was assessed by RT±PCR analysis. The size of the
expected product for Gata1 cDNA is 297 bp. RT±PCR analysis of Hprt
expression was used as an internal control; expected product size of cDNA
is 247 bp.
Table 2. Comparison of testes, epididymides, seminal vesicles weights and sperm counts of Gata1¯oxed:y and Gata1¯oxed:y::Dhh-Cre littermates at different
ages
Age Genotype n Testis Epididymus Seminal vesicles Sperm count per epididymus
(days) (mg) SD (mg) SD (mg) SD (3106) SD
24 ¯oxed:y 1 35.5 ± 10.0 ± 5.7 ± ± ±
¯oxed:y::Dhh-Cre 3 42.1 3.9 10.5 2.1 6.4 1.3 ± ±
52 ¯oxed:y 1 67.5 ± 23.2 ± 52.3 ± 18.0 ±
¯oxed:y::Dhh-Cre 1 90.5 ± 29.3 ± 60.5 ± 19.0 ±
74 ¯oxed:y 3 101.0 15.9 40.4 9.8 65.5 5.6 31.7 6.6
¯oxed:y::Dhh-Cre 4 102.0 11.5 38.0 1.8 61.6 9.6 28.5 6.6
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DISCUSSION
A ¯oxed allele of the Gata1 gene
Here, we describe the generation of a mouse line in which the
Gata1 gene has been ¯anked by loxP sites. After Cre-mediated
recombination, the coding sequences of the Gata1 gene are
deleted and a GFP reporter gene is brought under the control
of the Gata1 erythroid- and testis-speci®c promoters. How-
ever, we have been unable to detect expression of the GFP
reporter from the recombined locus, in either Sertoli or
erythroid cells (data not shown). Since expression of GFP was
also negative by RT±PCR analysis, a likely explanation is that
the part of the gene that is deleted by the recombination event
contains important regulatory regions for the expression of the
Gata1 gene. The Gata1 locus appears to contain multiple
regulatory elements (13,37±40). It is now known that at least
one of these elements resides in the area deleted in the
recombined locus (37). Thus, our data support the notion that
this element is important for appropriate erythroid expression
of the Gata1 gene in the context of the endogenous locus.
Apart from the testis-speci®c promoter, testis-speci®c enhan-
cer elements of Gata1 expression are not known. Our data
suggest that such elements reside in the area deleted by Cre in
the Gata1 conditional knockout locus described here. Most
importantly, insertion of the loxP sites and the GFP±neo
cassette did not appear to affect the expression of Gata1, as the
Gata1 conditional knockout mice developed and reproduced
normally.
The Sertoli cell-speci®c knockout of the Gata1 gene
Previously, a `knockdown' mutation of the testis promoter of
the mouse Gata1 gene has been generated. This mutation did
not show a Sertoli cell-speci®c phenotype (41). However, in
these experiments, it could not be excluded that residual Gata1
expression from the erythroid promoter masks the phenotype
in Sertoli cells. In the present study, we have used the Dhh-Cre
transgene to delete the Gata1 gene in Sertoli cells. This
promoter becomes active around E12.5 in pre-Sertoli cells,
long before Gata1 expression is normally activated in this cell
lineage at P7 (15,28). Thus, this is the ®rst description of the
consequences of a true Gata1 null mutation in Sertoli cells.
Our data demonstrate that a Sertoli cell-speci®c knockout of
Gata1 does not result in an apparent phenotype based on the
analysis of the expression of putative testis-speci®c Gata1
target genes, testis development, spermatogenesis and male
fertility. This is surprising since speci®c modulation of the
expression of Gata factors during testis development has been
reported, and a number of potential target genes have been
identi®ed (5,14,15,21±23,42). These target genes have been
found through in vitro promoter studies that utilise proximal
promoter elements to stimulate the expression of reporter
genes. These assays can only mimic the in vivo situation to a
limited extent. For instance, important regulatory elements
may be missing from the constructs used, the promoter tested
is not in its normal chromatin environment, and the cells
employed in these studies are usually transformed cells.
Furthermore, these apparently con¯icting data could be
reconciled by the possibility that Gata factors have over-
lapping functions in Sertoli cells in vivo. In this scenario,
expression of Gata target genes in Gata1 null Sertoli cells
would be certi®ed by the presence of another Gata factor. The
`endodermal' Gata4 and Gata6 are known to be expressed in
Sertoli cells (16,43). Gata4 promotes the expression of several
Sertoli cell-speci®c promoter constructs in tissue culture (4).
The model implicating Gata1 in the downregulation of Amh
expression predicts that in the absence of Gata1, Sertoli cells
would sustain high-level Amh expression directed by Gata4.
Aberrantly high Amh levels may result in a phenotype, since
overexpression of Amh in male mice affects sexual develop-
ment adversely (18). However, we do not ®nd any changes in
sexual development, or Amh expression at P14, in the Gata1
compound mutant males. Thus, we conclude that if Gata1 is
involved in the physiological downregulation of Amh
expression, it is not a pivotal regulator of this process.
Implications for the role of Gata factors in Sertoli cells
From our data, it would appear that the expression of Gata1 in
Sertoli cells has no functional signi®cance. We consider this
unlikely, since Sertoli cell-speci®c expression of Gata1 is very
speci®cally regulated, and is conserved between man and
mouse (5). In this regard, it is intriguing that two human males
bearing a GATA1 mutation (V205M) displayed cryptorchid-
ism (17). Although our data suggest that loss of Gata function
may not be responsible for the observed cryptorchidism, an
alternative explanation is that the V205M mutation has a
dominant-negative effect, resulting in a more drastic pheno-
type than complete loss of Gata1 activity in Sertoli cells. This
suggests functional redundancy of Gata factors in Sertoli cell
development. Opposing roles for endodermal (Gata4) versus
haematopoietic (Gata1) factors have been proposed in Sertoli
cells. Recently, it has been demonstrated that a Gata4 mutant
has severe impact on gonadal development (44). Functional
replacement of Gata1 by Gata2 has been established for
erythroid cells (36). We therefore propose that the haemato-
poietic Gata2 factor may compensate for the loss of Gata1
function in Sertoli cells, since it is expressed in the testis
(Table 3). The work reported here sets the stage to address this
issue through the analysis of compound Sertoli cell-speci®c
knockout mutants of Gata factors, using the Dhh-Cre mice as a
tool to circumvent the embryonic lethality generally
associated with Gata factor null mutations. Furthermore,
the Dhh expression construct could be used to express a
Table 3. RQ±PCR expression analysis of putative Gata1 target genes and
Gata transcription factors in testes from Gata1¯oxed:y and
Gata1¯oxed:y::Dhh-Cre mice at P14
¯oxed:y ¯oxed:y::Dhh-Cre
Threshold cycle SD Threshold cycle SD
Amh 26.6 1.2 25.5 0.7
Fshr 25.3 0.3 24.7 0.6
Inhibin a 23.5 0.4 24.1 0.6
Inhibin b-A 27.5 0.4 27.5 0.6
Inhibin b-B 22.8 0.1 23.1 0.1
Star 23.7 0.2 24.3 0.2
Cyp19 28.1 0.1 26.8 0.4
Gata2 27.6 0.4 26.4 0.6
Gata4 24.2 0.4 23.8 0.3
Gata6 24.7 0.2 24.6 0.3
Hprt 24.4 0.3 24.7 0.1
Cyclophilin A 20.2 0.1 19.7 0.0
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dominant-negative Gata protein, such as a Gata±engrailed
fusion protein (45±47) to prove that Gata factors have an
essential role in Sertoli cells.
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